The Cambridge Healthcare Innovations team has wide experience in a range of fields including dry powder inhalers, respiratory medicine, engineering, medtech, life sciences and pharma.
We also have a track record of innovations which have been developed into commercial products.
Co-Founder & CTO
David is passionate about improving the lives and wellbeing of patients. He has focused his 25 year career on the development of medical products, mainly in the field of respiratory drug delivery.
As a physicist he enjoys the complex and challenging science that underpins inhalation and has more than 50 patent applications in the field, many of which have become part of commercially successful products.
As CTO, David is responsible for the technical development of new products.
Warren brings more than 30 years of mechanical and product design experience across a range of highly regulated industries, including medical, food and aviation.
A pMDI and DPI expert, he has developed successful inhalation products across a range of formats, including multi-dose, blister, and reservoir-based devices.
As CHI’s Principal Engineer, Warren leads our design and engineering activities.
Co-Founder & Non-Executive Director
A successful design engineer and business owner whose products have won critical acclaim and commercial success, Mike brings both commercial and technical support to the CHI team.
His extensive experience includes consumer, industrial, medical and scientific markets, from concept to production.
As a non-executive director Mike takes an active role in company and programme oversight.
Mark is a successful business leader with a track record in growing companies in regulated industries, including Pharma and MedTech. Mark is currently the CEO of Wickham Micro, having previously held CEO roles at PBF Biotech and Intertek Melbourn.
Professor Darragh Murnane
Darragh is the Professor of Pharmaceutics at the University of Hertfordshire, and a past President of the UK and Ireland Aerosol Society. Darragh’s research and collaboration projects include materials and formulation science, product manufacture and the design and use of inhalation devices. Darragh is a member of the scientific review panel for the annual Drug Delivery to the Lungs (DDL) conference.